Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) Operating Margin (2022 - 2025)

Historic Operating Margin for Cardio Diagnostics Holdings (CDIO) over the last 4 years, with Q3 2025 value amounting to 59950.86%.

  • Cardio Diagnostics Holdings' Operating Margin fell 385379900.0% to 59950.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 41422.24%, marking a year-over-year decrease of 179088100.0%. This contributed to the annual value of 23977.86% for FY2024, which is 184625600.0% up from last year.
  • Per Cardio Diagnostics Holdings' latest filing, its Operating Margin stood at 59950.86% for Q3 2025, which was down 385379900.0% from 22457.51% recorded in Q2 2025.
  • Over the past 5 years, Cardio Diagnostics Holdings' Operating Margin peaked at 14398.71% during Q3 2023, and registered a low of 250321.79% during Q4 2022.
  • In the last 4 years, Cardio Diagnostics Holdings' Operating Margin had a median value of 29039.51% in 2023 and averaged 72278.39%.
  • Its Operating Margin has fluctuated over the past 5 years, first skyrocketed by 2000000000bps in 2023, then crashed by -1473585600bps in 2025.
  • Cardio Diagnostics Holdings' Operating Margin (Quarter) stood at 250321.79% in 2022, then skyrocketed by 88bps to 29039.51% in 2023, then decreased by -16bps to 33608.2% in 2024, then tumbled by -78bps to 59950.86% in 2025.
  • Its Operating Margin stands at 59950.86% for Q3 2025, versus 22457.51% for Q2 2025 and 173463.83% for Q1 2025.